RecruitingNCT05590442

Risk Model of Cognitive Impairment in Diabetes

Early Diagnosis and Risk Evaluation of Mild Cognitive Impairment in Diabetes


Sponsor

The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School

Enrollment

500 participants

Start Date

Sep 1, 2022

Study Type

OBSERVATIONAL

Conditions

Summary

Development and validation of a risk model for predicting the risk of mild cognitive impairment among individuals of type 2 diabetes.


Eligibility

Min Age: 40 YearsMax Age: 80 Years

Plain Language Summary

Simplified for easier understanding

This study is building a risk model to predict which people with type 2 diabetes are more likely to develop cognitive problems (memory and thinking difficulties). By identifying patterns early, doctors may be able to intervene before serious decline occurs. **You may be eligible if...** - You have been diagnosed with type 2 diabetes - You are between 40 and 80 years old - Your cognitive screening score (MoCA) is in the range of 19–30 (normal to mild impairment) **You may NOT be eligible if...** - You have a very low memory test score (MMSE under 24) - You have been diagnosed with another form of dementia, severe depression, or schizophrenia in the past 2 years - You have a neurological condition such as a brain injury, recent stroke, or brain tumor Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERTests

Cognitive assessments and olfactory tests


Locations(1)

Division of Endocrinology, the Affiliated Drum Tower Hospital of Nanjing University

Nanjing, Jiangsu, China

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05590442


Related Trials